I'd have to agree with you stainless, with all the trial results released to date indicating nothing but positives it would seem that FDA approval is but a matter of when the announcement from the US is made.
The potential of Epitans product is huge.
JMHO
Cheers,
Fig Jam
open briefing - epitan chairman & cfo on strategy , page-4
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.38 |
Change
2.210(14.6%) |
Mkt cap ! $870.8M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $17.71 | $15.16 | $5.878M | 346.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $17.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.39 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |